First Molecular Identification of Three Clinical Isolates of Fungi Causing Mucormycosis in Honduras.
Apophysomyces ossiformis
Honduras
Mucorales
Rhizopus oryzae
coronavirus disease (COVID-19) associated mucormycosis
mucormycosis
opportunistic fungal infections
Journal
Infectious disease reports
ISSN: 2036-7430
Titre abrégé: Infect Dis Rep
Pays: Switzerland
ID NLM: 101537203
Informations de publication
Date de publication:
07 Apr 2022
07 Apr 2022
Historique:
received:
23
03
2022
revised:
31
03
2022
accepted:
31
03
2022
entrez:
21
4
2022
pubmed:
22
4
2022
medline:
22
4
2022
Statut:
epublish
Résumé
Mucormycoses are rare but serious opportunistic fungal infections caused by filamentous organisms of the order Mucorales. Here we report the first molecular identification of Rhizopus oryzae (heterotypic synonym Rhizopus arrhizus), R. delemar, and Apophysomyces ossiformis as the etiological agents of three cases of severe mucormycosis in Honduras. Conventional microbiological cultures were carried out, and DNA was extracted from both clinical samples and axenic cultures. The ITS ribosomal region was amplified and sequenced. Molecular tools are suitable strategies for diagnosing and identifying Mucorales in tissues and cultures, especially in middle-income countries lacking routine diagnostic strategies.
Identifiants
pubmed: 35447883
pii: idr14020031
doi: 10.3390/idr14020031
pmc: PMC9027499
doi:
Types de publication
Journal Article
Langues
eng
Pagination
258-265Références
J Fungi (Basel). 2019 Nov 14;5(4):
pubmed: 31739583
Eur Ann Otorhinolaryngol Head Neck Dis. 2016 Apr;133(2):83-6
pubmed: 26361005
Pathogens. 2019 Nov 15;8(4):
pubmed: 31731617
J Fungi (Basel). 2021 Jul 29;7(8):
pubmed: 34436155
Clin Infect Dis. 2020 Sep 12;71(6):1367-1376
pubmed: 31802125
Clin Microbiol Infect. 2009 Oct;15 Suppl 5:66-70
pubmed: 19754761
Med Mycol. 2021 Dec 03;59(12):1202-1209
pubmed: 34550395
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146
pubmed: 34192610
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6241-6
pubmed: 22454494
Indian J Ophthalmol. 2021 Jul;69(7):1645-1647
pubmed: 34146000
J Clin Microbiol. 2006 Feb;44(2):340-9
pubmed: 16455881
Clin Infect Dis. 2008 Jun 15;46(12):1813-21
pubmed: 18462102
J Fungi (Basel). 2021 Aug 07;7(8):
pubmed: 34436180
Br J Oral Maxillofac Surg. 2021 Nov;59(9):1095-1098
pubmed: 34507870
BMC Infect Dis. 2020 Aug 18;20(1):614
pubmed: 32811466
N Engl J Med. 2012 Dec 6;367(23):2214-25
pubmed: 23215557
Sci Rep. 2017 Nov 21;7(1):15898
pubmed: 29162893
Medicine (Baltimore). 2016 Jul;95(27):e4185
pubmed: 27399143
J Clin Microbiol. 2014 Dec;52(12):4428-31
pubmed: 25297328
Persoonia. 2013 Jun;30:11-47
pubmed: 24027345
Mycobiology. 2019 Dec 30;48(1):29-36
pubmed: 32158603
Mycoses. 2022 Jan;65(1):65-70
pubmed: 34674319
BMJ Case Rep. 2021 Jun 24;14(6):
pubmed: 34167998
BMJ Case Rep. 2021 Apr 27;14(4):
pubmed: 33906877
Vaccines (Basel). 2021 Jul 27;9(8):
pubmed: 34451951
Microorganisms. 2021 Mar 04;9(3):
pubmed: 33806386
J Fungi (Basel). 2019 Mar 21;5(1):
pubmed: 30901907
Med Mycol. 2015 Feb 1;53(2):99-106
pubmed: 25431472
MMWR Morb Mortal Wkly Rep. 2021 Dec 17;70(50):1747-1749
pubmed: 34914675
Rev Iberoam Micol. 2015 Apr-Jun;32(2):63-70
pubmed: 25543322
Antimicrob Agents Chemother. 2018 Jul 27;62(8):
pubmed: 29891608
Clin Microbiol Infect. 2019 Jan;25(1):26-34
pubmed: 30036666
Med Mycol. 2018 Apr 1;56(suppl_1):93-101
pubmed: 29538730
Int J Antimicrob Agents. 2017 Nov;50(5):617-621
pubmed: 28802855
Lancet Infect Dis. 2019 Dec;19(12):e405-e421
pubmed: 31699664
Rev Iberoam Micol. 2010 Jun 30;27(2):80-9
pubmed: 20199897
Lancet Infect Dis. 2016 Jul;16(7):828-837
pubmed: 26969258
Rev Peru Med Exp Salud Publica. 2021 Jul-Sep;38(3):472-473
pubmed: 34932752
J Fungi (Basel). 2020 Nov 02;6(4):
pubmed: 33147877